Robert Bonitz
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,000 | 347 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Davol Inc. | $980.41 | 14 | $0 (2024) |
| Boston Scientific Corporation | $831.15 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $812.78 | 46 | $0 (2024) |
| Integra LifeSciences Corporation | $527.76 | 7 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $514.75 | 26 | $0 (2024) |
| COLOPLAST CORP | $445.17 | 23 | $0 (2024) |
| PFIZER INC. | $413.99 | 28 | $0 (2024) |
| Antares Pharma, Inc. | $270.72 | 16 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $268.27 | 17 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $253.61 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,569 | 67 | Davol Inc. ($160.19) |
| 2023 | $2,042 | 85 | Integra LifeSciences Corporation ($341.48) |
| 2022 | $1,576 | 63 | Davol Inc. ($381.67) |
| 2021 | $791.83 | 32 | Boston Scientific Corporation ($352.53) |
| 2020 | $594.87 | 19 | Boston Scientific Corporation ($227.64) |
| 2019 | $416.73 | 30 | Astellas Pharma US Inc ($129.61) |
| 2018 | $330.50 | 23 | Astellas Pharma US Inc ($114.29) |
| 2017 | $679.75 | 28 | Astellas Pharma US Inc ($282.21) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Olympus America Inc. | Bovie (Device) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Urology Gynecology | ||||||
| 12/03/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/11/2024 | Laborie Medical Technologies Corp. | Urgent PC Neuromodulation System (Device) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Urology | ||||||
| 11/05/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $117.12 | General |
| Category: UROLOGY | ||||||
| 11/05/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $57.56 | General |
| Category: Surgical Care | ||||||
| 11/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: HORMONE THERAPY | ||||||
| 10/28/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Food and Beverage | In-kind items and services | $89.71 | General |
| Category: Surgery | ||||||
| 10/24/2024 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $70.48 | General |
| Category: Surgery | ||||||
| 10/23/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $63.79 | General |
| Category: LithoVue_URO | ||||||
| 10/22/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $29.36 | General |
| 10/21/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Continence Care | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/23/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/16/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 09/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,647 | 3,463 | $1.6M | $202,190 |
| 2022 | 21 | 2,198 | 2,877 | $1.2M | $170,992 |
| 2021 | 21 | 1,971 | 2,545 | $719,513 | $157,211 |
| 2020 | 20 | 1,851 | 2,368 | $518,016 | $137,244 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 458 | 607 | $304,107 | $42,583 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 290 | 337 | $239,270 | $30,163 | 12.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 108 | 134 | $179,962 | $26,860 | 14.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 141 | 154 | $163,856 | $21,424 | 13.1% |
| 55867 | Simple surgical subtotal removal of prostate using laparoscope | Facility | 2023 | 14 | 14 | $108,738 | $12,201 | 11.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 86 | $84,968 | $11,532 | 13.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 107 | 149 | $56,918 | $9,327 | 16.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 97 | 97 | $59,752 | $8,110 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $56,730 | $7,890 | 13.9% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 24 | 80 | $28,960 | $3,916 | 13.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 18 | 18 | $25,362 | $3,758 | 14.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 21 | 27 | $68,715 | $3,161 | 4.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 237 | 314 | $18,840 | $2,842 | 15.1% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 14 | 14 | $15,162 | $2,388 | 15.7% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 21 | 21 | $29,589 | $2,252 | 7.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $15,691 | $2,239 | 14.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 656 | 989 | $16,319 | $2,164 | 13.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 29 | 32 | $19,968 | $2,026 | 10.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 39 | $12,129 | $1,888 | 15.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 18 | 18 | $14,382 | $1,516 | 10.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 18 | 18 | $5,814 | $729.98 | 12.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 60 | $4,740 | $715.67 | 15.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 21 | 21 | $16,779 | $561.75 | 3.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 22 | $4,092 | $555.52 | 13.6% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 20 | 20 | $6,460 | $504.80 | 7.8% |
About Robert Bonitz
Robert Bonitz is a Student in an Organized Health Care Education/Training Program healthcare provider based in Shrewsbury, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2012. The National Provider Identifier (NPI) number assigned to this provider is 1104182716.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Bonitz has received a total of $8,000 in payments from pharmaceutical and medical device companies, with $1,569 received in 2024. These payments were reported across 347 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,000).
As a Medicare-enrolled provider, Bonitz has provided services to 8,667 Medicare beneficiaries, totaling 11,253 services with total Medicare billing of $667,638. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Urology
- Location Shrewsbury, NJ
- Active Since 04/09/2012
- Last Updated 11/13/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1104182716
Products in Payments
- XTANDI (Drug) $556.52
- Integra (Device) $527.76
- PROVENGE (Drug) $514.75
- ORGOVYX (Drug) $299.50
- INTERSTIM (Device) $276.12
- SpeediCath (Device) $270.63
- XIAFLEX (Biological) $270.14
- Phasix Mesh (Device) $233.39
- LITHOVUE (Device) $220.35
- Xtandi (Drug) $211.60
- XYOSTED (Drug) $199.12
- AMS (Device) $198.22
- BOTOX (Biological) $189.00
- Myrbetriq (Drug) $165.02
- ARISTA AH FlexiTip (Device) $163.92
- ARISTA AH FLEXITIP (Device) $160.56
- LithoVue (Device) $155.37
- GEMTESA (Drug) $151.45
- AQUABEAM SYSTEM (Device) $150.45
- XENAB (Device) $147.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Shrewsbury
Ginette Illuzzi, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $2,909
Andrew Chen, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $404.64
Noorevelyn Sarsar
Student in an Organized Health Care Education/Training Program — Payments: $94.72
Daniel Graham, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $15.51
Jordan Trubiano, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $13.30
Ms. Kristi Troccia
Student in an Organized Health Care Education/Training Program